4/A: CareDx Director Corrects Stock Option Exercise Price in Amended SEC Filing
SEC Form 4/A (Amendment to Statement of Changes in Beneficial Ownership)
George Bickerstaff, a director at CareDx, Inc., filed an amendment to a previous SEC Form 4 to correct the exercise price of a stock option.
Summary
- George Bickerstaff, a director of CareDx, Inc., filed an amended Form 4 with the SEC to correct the exercise price of a stock option.
- The original filing contained an error in the exercise price of the stock option.
- The corrected exercise price is $14.19.
- The stock option grants Bickerstaff the right to buy 16,048 shares of CareDx common stock.
- The options vest monthly from July 14, 2024, through June 14, 2025.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of earliest transaction (stock option grant) |
| 06/18/2024 | Date of original Form 4 filing |
| 07/14/2024 | First vesting date for the stock option (1/12th of shares) |
| 06/14/2025 | Final vesting date for the stock option |
| 06/20/2024 | Date of amended Form 4/A filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.